Quipt Home Medical Corp T.QIPT

RE:RE:RE:RE:longs aren't budging

[lscfa]

Tropicalsun wrote:

gibbonsj wrote: Tropical. With volume being what it is it's clear that few are interested in selling. What shares have been traded include a lot of head fakes to bring share price down. Whether that is short covering or patient trading really makes no difference It is very difficult in low volume situations like this to draw any conclusions but the consensus is the company is doing very well and the debentures are out of the way which improves the bottom line and the company has stayed with its calendar year guidance. That is the only reliable information we have so that's what we have to go with. The trading we see on a day-to-day basis is more often than not low volume smoke and mirrors.

gibbonsj, I agree with your post. I must admit after looking at Iscfa's recent post I am confused with these analysts revenue guidance for calender 2022 year end. Here is what we know, the latest revenue figure stated by the company is around 165 million, again they have maintained their target of between $180 and $190 million revenue run rate by the end of calendar 2022. I don't see how they get there, do you?

The charts posted have the company exiting 2022 at $149 million on the low end and $151 million on the high end, 2023 shows I believe $192 million, so what am I missing? Iscfa, please feel free to chime in this conversation. I think you used a figure of $160 million back sometime ago, so are these charts not up to date?

 The historical no.s and forecast no.s are for fiscal years, not calender yers.